What is the Kilitch Drugs (India) Ltd share price today?

The share price of NSE:KILITCH-BE on 07 Sep 2026 (as of 10:59:39 IST) is ₹186.89.

What is the NSE:KILITCH-BE 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:KILITCH-BE 52 week high low range shows a high of ₹219.50 and a low of ₹117.25.

What is the Kilitch Drugs (India) Ltd market cap?

As on 07 Sep 2026, Kilitch Drugs (India) Ltd market cap is ₹629.66 Cr.

What is the shareholding pattern of Kilitch Drugs (India) Ltd Stock?

The shareholding pattern of Kilitch Drugs (India) Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 63.77% Foreign Institutional Investors (FII): 0.12% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 36.11% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Kilitch Drugs (India) Ltd?

The Price-to-Earnings (PE) ratio of Kilitch Drugs (India) Ltd is 20.95, and the Price-to-Book (PB) ratio is 1.60, as on 07 Sep 2026.

Kilitch Drugs (India) Share Price

217.23-4.39 (-1.98%)

+23.85% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.98%

1 Week

+13.47%

1 Month

+27.01%

3 Month

+17.23%

6 Month

+56.34%

YTD

+24.06%

1 Year

+23.85%

5 Year

+160.93%

10 Year

+1217.41%

Max

+230.21%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

211.00

191.80

166.15

156.00

117.25

High

232.50

About

Kilitch Drugs (India) Limited is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms such as Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

KILITCH-BENSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

215.75+24.3 (12.69%)

191.80

232.50

783Cr

Kilitch Drugs (India) Share Price

217.23-4.39 (-1.98%)

+23.85% past 1 Year

Financial overview

Compounded Sales Growth

10 years27%

5 years28%

3 years19%

Last year19%

Compounded Profit Growth

10 years-

5 years52%

3 years42%

Last year18%

Stock Price CAGR

10 years30%

5 years22%

3 years22%

1 year26%

Return on Equity

10 years5%

5 years9%

3 years11%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
27%	28%	19%	19%
-	52%	42%	18%
30%	22%	22%	26%
5%	9%	11%	12%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

KILITCH-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
215.75	₹783 Cr	26.04	0.83	9.7	₹30 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Trade Payables

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2012	Mar 2011	Mar 2010
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹35 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹14 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr
₹35 L	₹35 L	₹35 L	₹5 Cr	₹3 Cr	₹35 L	₹1 Cr	₹1 Cr	₹4 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr
₹244 Cr	₹186 Cr	₹160 Cr	₹131 Cr	₹121 Cr	₹111 Cr	₹102 Cr	₹105 Cr	₹95 Cr	₹87 Cr	₹94 Cr	₹105 Cr	₹100 Cr	₹69 Cr	₹60 Cr
₹244 Cr	₹186 Cr	₹160 Cr	₹131 Cr	₹121 Cr	₹111 Cr	₹102 Cr	₹105 Cr	₹95 Cr	₹87 Cr	₹94 Cr	₹105 Cr	₹100 Cr	₹69 Cr	₹60 Cr
₹280 Cr	₹202 Cr	₹176 Cr	₹152 Cr	₹139 Cr	₹127 Cr	₹118 Cr	₹121 Cr	₹112 Cr	₹101 Cr	₹109 Cr	₹120 Cr	₹115 Cr	₹84 Cr	₹75 Cr
-₹3 Cr	-₹2 Cr	-₹62 L	-₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹73 L	₹0	₹0	₹0	₹1 Cr	₹2 Cr	₹0
₹59 Cr	₹28 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹4 L	₹0	₹43 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹1 L	₹0
-₹5 Cr	-₹3 Cr	-₹3 Cr	-₹2 Cr	-₹2 Cr	-₹1 Cr	-₹97 L	-₹1 Cr	-₹2 Cr	-₹2 Cr	-₹95 L	-₹51 L	₹26 L	₹51 L	-₹5 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹37 L	₹38 L	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹15 L	₹0	₹0
₹68 L	₹25 L	₹17 L	₹7 L	₹28 L	₹38 L	₹39 L	₹41 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹55 Cr	₹25 Cr	-₹2 Cr	-₹2 Cr	-₹1 Cr	-₹90 L	-₹58 L	-₹62 L	-₹2 Cr	-₹2 Cr	-₹95 L	-₹51 L	₹82 L	₹89 L	₹38 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹80 Cr	₹54 Cr	₹26 Cr	₹41 Cr	₹43 Cr	₹54 Cr	₹7 Cr	₹4 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹2 Cr	₹4 Cr	₹10 Cr	₹12 Cr
₹3 Cr	₹33 L	₹28 L	₹25 L	₹57 L	₹1 Cr	₹1 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹1 Cr	₹38 Cr	₹2 Cr
₹30 Cr	₹22 Cr	₹32 Cr	₹22 Cr	₹20 Cr	₹15 Cr	₹13 Cr	₹9 Cr	₹92 L	₹69 L	₹19 L	₹10,000	₹9 Cr	₹16 Cr	₹0
₹9 Cr	₹8 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹77 L	₹55 L	₹47 Cr	₹2 Cr	₹7 Cr
₹122 Cr	₹84 Cr	₹64 Cr	₹69 Cr	₹69 Cr	₹73 Cr	₹22 Cr	₹20 Cr	₹15 Cr	₹12 Cr	₹8 Cr	₹7 Cr	₹60 Cr	₹66 Cr	₹21 Cr
₹453 Cr	₹310 Cr	₹237 Cr	₹218 Cr	₹208 Cr	₹202 Cr	₹142 Cr	₹143 Cr	₹126 Cr	₹110 Cr	₹116 Cr	₹126 Cr	₹177 Cr	₹153 Cr	₹135 Cr
₹76 L	₹76 L	₹76 L	₹76 L	₹76 L	₹76 L	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹8 Cr	₹4 Cr	₹3 Cr
₹89 Cr	₹49 Cr	₹32 Cr	₹22 Cr	₹20 Cr	₹15 Cr	₹13 Cr	₹9 Cr	₹92 L	₹69 L	₹19 L	₹10,000	₹9 Cr	₹53 Cr	₹43 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹124 Cr	₹118 Cr	₹112 Cr	₹111 Cr	₹108 Cr	₹71 Cr	₹71 Cr	₹69 Cr	₹68 Cr	₹66 Cr	₹66 Cr	₹23 Cr	₹21 Cr	₹74 Cr	₹71 Cr
₹57 Cr	₹54 Cr	₹50 Cr	₹47 Cr	₹44 Cr	₹41 Cr	₹39 Cr	₹37 Cr	₹35 Cr	₹33 Cr	₹23 Cr	₹13 Cr	₹12 Cr	₹32 Cr	₹27 Cr
₹67 Cr	₹64 Cr	₹62 Cr	₹64 Cr	₹65 Cr	₹30 Cr	₹32 Cr	₹32 Cr	₹33 Cr	₹33 Cr	₹42 Cr	₹9 Cr	₹9 Cr	₹42 Cr	₹44 Cr
₹140 Cr	₹47 Cr	₹6 Cr	₹4 Cr	₹3 Cr	₹65 Cr	₹30 Cr	₹20 Cr	₹3 Cr	₹66 L	₹0	₹0	₹0	₹43 Cr	₹22 Cr
₹23 Cr	₹23 Cr	₹23 Cr	₹23 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹25 Cr	₹26 Cr	₹27 Cr	₹26 Cr	₹47 Cr	₹72 L	₹22 L	₹1 Cr
₹23 Cr	₹23 Cr	₹23 Cr	₹23 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹25 Cr	₹26 Cr	₹27 Cr	₹26 Cr	₹47 Cr	₹72 L	₹22 L	₹1 Cr
₹1 Cr	₹1 Cr	₹72 L	₹62 L	₹46 L	₹44 L	₹36 L	₹34 L	₹22 L	₹8 L	₹20 L	₹23 Cr	₹25 L	₹19 L	₹0
₹50,000	₹2 L	₹1 L	₹2 L	₹2 Cr	₹2 Cr	₹54 L	₹0	₹79 L	₹79 L	₹0	₹0	₹0	₹0	₹0
₹231 Cr	₹136 Cr	₹92 Cr	₹91 Cr	₹94 Cr	₹122 Cr	₹86 Cr	₹78 Cr	₹63 Cr	₹62 Cr	₹68 Cr	₹79 Cr	₹10 Cr	₹85 Cr	₹67 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹52 Cr	₹50 Cr	₹49 Cr	₹39 Cr	₹47 Cr	₹36 Cr	₹28 Cr	₹28 Cr	₹30 Cr	₹26 Cr	₹23 Cr	₹25 Cr	₹138 Cr	₹25,000	₹0
₹12 Cr	₹15 Cr	₹4 Cr	₹2 Cr	₹5 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹17 Cr	₹12 Cr
₹120 Cr	₹85 Cr	₹63 Cr	₹54 Cr	₹41 Cr	₹23 Cr	₹16 Cr	₹19 Cr	₹21 Cr	₹15 Cr	₹16 Cr	₹13 Cr	₹15 Cr	₹39 Cr	₹48 Cr
₹17 Cr	₹10 Cr	₹20 Cr	₹20 Cr	₹10 Cr	₹13 Cr	₹3 Cr	₹8 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹12 Cr	₹9 Cr	₹4 Cr
₹76 L	₹6 Cr	₹2 Cr	₹54 L	₹36 L	₹5 L	₹4 L	₹16 L	₹36 L	₹7 L	₹3 L	₹7 L	₹51 L	₹100 L	₹5 L
₹21 Cr	₹8 Cr	₹8 Cr	₹10 Cr	₹10 Cr	₹5 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹22 L	₹1 Cr	₹3 Cr
₹222 Cr	₹174 Cr	₹146 Cr	₹126 Cr	₹114 Cr	₹80 Cr	₹56 Cr	₹65 Cr	₹63 Cr	₹49 Cr	₹47 Cr	₹47 Cr	₹167 Cr	₹68 Cr	₹67 Cr
₹101 Cr	₹90 Cr	₹82 Cr	₹58 Cr	₹45 Cr	₹7 Cr	₹34 Cr	₹45 Cr	₹48 Cr	₹37 Cr	₹39 Cr	₹40 Cr	₹107 Cr	₹1 Cr	₹46 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 L	₹3 L	₹0	₹0	₹36 L
₹453 Cr	₹310 Cr	₹237 Cr	₹218 Cr	₹208 Cr	₹202 Cr	₹142 Cr	₹143 Cr	₹126 Cr	₹110 Cr	₹116 Cr	₹126 Cr	₹177 Cr	₹153 Cr	₹135 Cr
₹80	₹126	₹109	₹94	₹87	₹82	₹76	₹78	₹79	₹75	₹81	₹90	₹86	₹62	₹55
₹80	₹61	₹107	₹94	₹87	₹82	₹76	₹78	₹79	₹75	₹81	₹90	₹86	₹62	₹55

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent of Subsidiaries under liquidations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2012	Mar 2011	Mar 2010
₹39 Cr	₹34 Cr	₹19 Cr	₹12 Cr	₹10 Cr	₹5 Cr	₹2 Cr	₹9 Cr	₹6 Cr	-₹9 Cr	-₹12 Cr	-₹95 L	-₹10 Cr	₹13 Cr	₹14 Cr
₹8 Cr	₹1 Cr	₹10 Cr	₹10 Cr	₹4 Cr	₹3 Cr	-₹1 Cr	₹2 Cr	₹2 Cr	₹11 Cr	₹9 Cr	₹2 Cr	₹7 Cr	₹9 Cr	₹7 Cr
-₹12 Cr	-₹10 Cr	-₹24 Cr	-₹15 Cr	-₹5 Cr	₹39 Cr	₹6 Cr	-₹6 Cr	-₹7 Cr	-₹1 Cr	₹20 Cr	-₹9 Cr	-₹27 Cr	-₹17 L	-₹5 Cr
₹34 Cr	₹26 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹47 Cr	₹7 Cr	₹4 Cr	₹1 Cr	₹1 Cr	₹17 Cr	-₹8 Cr	-₹29 Cr	₹22 Cr	₹15 Cr
₹24 Cr	₹18 Cr	-₹2 Cr	₹3 Cr	₹6 Cr	₹46 Cr	₹4 Cr	₹29 L	₹1 Cr	₹1 Cr	₹17 Cr	-₹8 Cr	-₹29 Cr	₹22 Cr	₹12 Cr
-₹100 Cr	-₹40 Cr	-₹8 Cr	₹8 Cr	-₹15 Cr	-₹38 Cr	-₹10 Cr	-₹14 Cr	-₹4 Cr	-₹2 Cr	-₹20 Cr	-₹31 Cr	₹41 Cr	-₹24 Cr	-₹20 Cr
₹82 Cr	₹13 Cr	₹9 Cr	-₹72 L	₹7 Cr	₹2 Cr	₹85 L	₹17 Cr	₹6 Cr	-₹4 L	₹11 L	-₹6 L	-₹9 Cr	₹7 Cr	₹7 Cr
₹6 Cr	-₹9 Cr	-₹88 L	₹10 Cr	-₹2 Cr	₹10 Cr	-₹5 Cr	₹3 Cr	₹2 Cr	-₹45 L	-₹2 Cr	-₹39 Cr	₹2 Cr	₹6 Cr	-₹1 Cr
₹10 Cr	₹19 Cr	₹20 Cr	₹10 Cr	₹13 Cr	₹3 Cr	₹8 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹44 Cr	₹9 Cr	₹4 Cr	₹5 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹70,000	₹0	₹0	₹0	₹0
₹16 Cr	₹10 Cr	₹19 Cr	₹20 Cr	₹10 Cr	₹13 Cr	₹3 Cr	₹8 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹5 Cr	₹12 Cr	₹9 Cr	₹4 Cr

Fundamental Ratios

Consolidated

Standalone

Kilitch Drugs (India) Share Price

217.23-4.39 (-1.98%)

+23.85% past 1 Year

Shareholding summary

Promoters

63.77%

FII

0.12%

DII

Others

36.11%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
63.77%	63.77%	63.77%	63.77%	69.23%	69.23%
0.12%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
36.11%	36.23%	36.23%	36.23%	30.77%	30.77%

Bulk & block deals

Name

Shreni Shares Pvt

Bp Fintrade Private Limited

Shah Dipak Kanayalal

Bp Fintrade Private Limited

Shah Dipak Kanayalal

Ronak Bansal

Sudhir Mohanlal Joshi

Aruna Dinesh Shah

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
28 Oct 2025	Purchase	1.30 Cr	₹401.82	32.33 K	Bulk	0.092479	NSE
28 Oct 2025	Sell	4.77 Cr	₹405.58	1.17 L	Bulk	0.336069	NSE
06 Mar 2018	Purchase	75.37 L	₹96.36	78.21 K	Bulk	0.223714	NSE
06 Mar 2018	Sell	64.26 L	₹96.35	66.70 K	Bulk	0.190778	NSE
06 Mar 2018	Sell	56.23 L	₹98.98	56.81 K	Bulk	0.162495	NSE
01 Mar 2018	Sell	92.70 L	₹115.88	80 K	Bulk	0.228822	NSE
27 Feb 2018	Purchase	88.71 L	₹122.90	72.18 K	Bulk	0.206467	NSE
27 Feb 2018	Sell	94.76 L	₹131.28	72.18 K	Bulk	0.206467	NSE
22 Jan 2018	Purchase	1.28 Cr	₹85.40	1.50 L	Bulk	0.430215	BSE
22 Jan 2018	Purchase	1.34 Cr	₹89.32	1.50 L	Bulk	0.430186	BSE

Insider trading & SAST

Client name

Mr Bhavin Mehta

Mira Bhavin Mehta

Mira Mehta

Bhavin Mukund Mehta

Mira Bhavin Mehta

Bhavin Mehta

Bhavin Mukund Mehta

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
24 Dec 2024	Promoter	Pledge	—	—	—	1.03 L	18 Sep 2020	Creation	1,03,300	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	—	1.03 L	22 Oct 2020	Release	0	SAST	Reg31	—
02 Sep 2024	Promoter	Acquisition	5.23	5.23	—	8.41 L	23 Aug 2024	Inter-se Transfer	8,41,046	SAST	29(1)	—
02 Sep 2024	Promoter	Disposal	5.23	15.69	—	8.41 L	23 Aug 2024	Inter-se Transfer	25,23,138	SAST	29(2)	—
02 Sep 2024	Other	Acquisition	5.23	—	—	8.41 L	23 Aug 2024	-	—	SAST	10(6)	—
28 Aug 2024	Promoter & Director	Disposal	5.229638	15.69	—	8.41 L	23 Aug 2024	Inter-se Transfer	25,23,138	Insider Trading	—	Equity Shares
28 Aug 2024	Director	Acquisition	5.229638	5.23	—	8.41 L	23 Aug 2024	Inter-se Transfer	8,41,046	Insider Trading	—	Equity Shares
14 Aug 2024	Promoter	Acquisition	5.23	—	—	8.41 L	23 Aug 2024	—	—	SAST	10(5)	—
27 Apr 2022	Other	Acquisition	7.13	—	—	11.12 L	22 Apr 2022	-	—	SAST	10(6)	—
25 Apr 2022	Director	Acquisition	7.134813	19.96	—	11.12 L	22 Apr 2022	Inter-se Transfer	31,14,184	Insider Trading	—	Equity Shares

Kilitch Drugs (India) Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Kilitch Drugs (India) Share Price

Kilitch Drugs (India) Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Kilitch Drugs (India) Share Price

Kilitch Drugs (India) Share Price

Oscillators

Moving averages

Kilitch Drugs (India) Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Kilitch Drugs (India) Share Price

Corporate Actions

Company details

Kilitch Drugs (India) Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Kilitch Drugs (India) Share Price

News

Kilitch Drugs begins nutraceutical production at new Raigad manufacturing unit

Kilitch Drugs Approves 1:1 Bonus Share Issue; Board Meeting on 11th February 2026

Kilitch Drugs Q3 FY26 EBITDA Declines to Rs 6.20 Crores, Margin at 11.45% YoY.

Kilitch Drugs Q3 FY26 Results: Net Profit Declines 26.67% YoY to Rs 4.40 Crores

Kilitch Drugs (India) consolidated Q2 profit marginally down, EBITDA margin improves YoY, revenue up modestly

Kilitch Drugs(India) - Quaterly Results

Kilitch Drugs(India) reports Profit after tax of 4.79 Crores, in the June 2025 quarter

Kilitch Drugs(India) - Quaterly Results

Kilitch Drugs: Q1 Ebitda 3.30 Crores Rupees Vs 1.70 Crores (Yoy) || Q1 Ebitda Margin 7.56% Vs 4.96% (Yoy)

Kilitch Drugs: Q1 Cons Net Profit 3.00 Crores Rupees Vs 1.30 Crores (Yoy) || Q1 Revenue 43.10 Crores Rupees Vs 33.50 Crores (Yoy)

Kilitch Drugs India informs about board meeting

Kilitch Drugs: Co Board Approves Rights Issue Price At 357 Rupees Per Share. ???

Kilitch Drugs: Q4 Ebitda 13.91 Crores Rupees Vs 5.20 Crores (Yoy) || Q4 Ebitda Margin 24.7% Vs 13.33% (Yoy)

Kilitch Drugs: Q4 Revenue 56.30 Crores Rupees Vs 39.10 Crores (Yoy)

Kilitch Drugs: Q4 Sl Net Profit 10.44 Crores Rupees Vs 4.68 Crores (Yoy); 5.65 Crores (Qoq)

Kilitch Drugs (India): Q3 Ebitda 8.70 Crores Rupees Vs 2.30 Crores (Yoy) || Q3 Ebitda Margin 15.54% Vs 7.14% (Yoy)

Kilitch Drugs (India): Q3 Cons Net Profit 6.00 Crores Rupees Vs 2.90 Crores (Yoy); 8.60 Crores (Qoq) || Q3 Revenue 56.20 Crores Rupees Vs 31.80 Crores (Yoy)

Kilitch Drugs (India): Co Invests $200,000 In Kilitch Estro Biotech

Kilitch Drugs (India): Q2 Net Profit 8.60 Crores Rupees Vs 4.70 Crores (Yoy) || Q2 Revenue 47.50 Crores Rupees Vs 41.20 Crores (Yoy)

Kilitch Drugs (India): Q4 Ebitda 5.22 Crores Rupees Vs 6.69 Crores (Yoy) || Q4 Ebitda Margin 13.33% Vs 15.45% (Yoy)

Kilitch Drugs (India) Ltd Share Price Today

Kilitch Drugs (India) Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator